Product Name | MF | CAS | Details |
---|
benzofuran-6-carboxylic acid | C9H6O3 | 77095-51-3 | Details |
Canertinib | C24H25ClFN5O3 | 267243-28-7 | Details |
2,4-Dimethoxyiodobenzene | C8H9IO2 | 20469-63-0 | Details |
Foretinib (GSK1363089) | C34H34F2N4O6 | 849217-64-7 | Details |
1,4-Diiodobenzene | C6H4I2 | 624-38-4 | Details |
4-Iodobiphenyl | C12H9I | 1591-31-7 | Details |
4-(METHYLAMINO)-3-NITROBENZOIC ACID | C8H8N2O4 | 41263-74-5 | Details |
3,4-Dichloroiodobenzene | C6H3Cl2I | 20555-91-3 | Details |
7H-Furo[3,2-g][1]benzopyran-7-one, 3-(bromomethyl)-2,5,9-trimethyl- | C15H13BrO3 | 127301-25-1 | Details |
5-Bromo-1,3-dichloro-2-fluorobenzene | C6H2BrCl2F | 17318-08-0 | Details |
Fedratinib | C27H36N6O3S | 936091-26-8 | Details |
(4R)-N-(tert-Butyloxycarbonyl)-4-(cyanoMethyl)-L-glutaMic Acid 1,5-DiMethyl Ester | C14H22N2O6 | 328086-57-3 | Details |
Topotecan | C23H23N3O5 | 123948-87-8 | Details |
Epertinib hydrochloride | C30H28Cl2FN5O3 | 2071195-74-7 | Details |
1-Iodo-3,5-dimethylbenzene | C8H9I | 22445-41-6 | Details |
Benzenepropanoic acid,a-hydroxy-b-methoxy-b-phenyl-,(aS)- | C16H16O4 | 178306-52-0 | Details |
2,3,5,9-tetramethyl-7H-furo[3,2-g][1]benzopyran-7-one | C15H14O3 | 113969-43-0 | Details |
N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride | C27H30ClN7O3 | 211914-50-0 | Details |
(1R,2S,5S)-Methyl 3-((S)-2-(3-(t-butyl)ureido)-3,3-diMethyl butanoyl)-6,6-diMethyl-3-azabicyclo [3.1.0]hexane-2-carboxylate | C20H34N2O5 | 394735-26-3 | Details |
2-Chloro-6-iodo-4-(trifluoromethyl)aniline | C7H4ClF3IN | 1065102-88-6 | Details |
Ningetinib Tosylate | C38H37FN4O8S | 1394820-77-9 | Details |
(2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide | C14H17N3O3 | 1192651-49-2 | Details |
Bis(4-bromophenyl) ether | C12H8Br2O | 2050-47-7 | Details |
(3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide | C25H26N6O2 | 1353644-70-8 | Details |
1-((2S,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one | C15H19N5O | 1792180-81-4 | Details |
1-Bromo-2,3-dichlorobenzene | C6H3BrCl2 | 56961-77-4 | Details |
2-Iodobiphenyl | C12H9I | 2113-51-1 | Details |
4-Acetylbenzoic acid | C9H8O3 | 586-89-0 | Details |
HEXYL CHLOROFORMATE | C7H13ClO2 | 6092-54-2 | Details |
3-Pyrrolidinepropanamide, α-amino-2-oxo-, (αS,3S)- | C7H13N3O2 | 2628280-47-5 | Details |
2-Bromo-9,9-dimethylfluorene | C15H13Br | 28320-31-2 | Details |
3-Bromo-L-phenylalanine | C9H10BrNO2 | 82311-69-1 | Details |
3-[(3-AMINO-4-METHYLAMINO-BENZOYL)-PYRIDIN-2-YL-AMINO]-PROPIONIC ACID ETHYL ESTER | C18H22N4O3 | 212322-56-0 | Details |
ETHYL N-[4-(METHYLAMINO)-3-NITROBENZOYL]-N-PYRIDIN-2-YL-SS-ALANINATE | C18H20N4O5 | 429659-01-8 | Details |
4-Bromo-4'-fluorobiphenyl | C12H8BrF | 398-21-0 | Details |
1-Chloro-4-iodobenzene | C6H4ClI | 637-87-6 | Details |
2-IODO-9H-FLUORENE | C13H9I | 2523-42-4 | Details |
3-Hydroxy-4-nitrobenzoic acid | C7H5NO5 | 619-14-7 | Details |
4-Iodotoluene | C7H7I | 624-31-7 | Details |
3-BROMO-4-FLUOROBIPHENYL | C12H8BrF | 306935-88-6 | Details |
3,5-Dichlorobenzoic acid | C7H4Cl2O2 | 51-36-5 | Details |
2-Propenamide, N-[2-[2-(dimethylamino)ethoxy]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]- | C27H30N6O3 | 1835667-12-3 | Details |
3-Pyrrolidinepropanamide, α-amino-2-oxo-, hydrochloride | C7H14ClN3O2 | 2628280-48-6 | Details |
(1R,2S,5S)-3-((S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid | C16H23F3N2O4 | 2755812-45-2 | Details |
1,3-Dibromo-5-chlorobenzene | C6H3Br2Cl | 14862-52-3 | Details |
1H-Isoindole-1,3(2H)-dione,2-(2-hydroxyethyl)- | C10H9NO3 | 3891-07-4 | Details |
Boceprevir Key interMediate | C19H32N2O5 | 394735-37-6 | Details |
1-Bromo-4-iodobenzene | C6H4BrI | 589-87-7 | Details |
2-(tert-butoxycarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid | C15H17Cl2NO4 | 851784-82-2 | Details |
1,4-dibromonaphthalene | C10H6Br2 | 83-53-4 | Details |
Vecabrutinib | C22H24ClF4N7O2 | 1510829-06-7 | Details |
3-Chloro-2-butanone | C4H7ClO | 4091-39-8 | Details |
2,3,5-TRIBROMO-4-METHYLTHIOPHENE | C5H3Br3S | 67869-13-0 | Details |
2-(Methylamino)pyridine-3-methanol | C7H10N2O | 32399-12-5 | Details |
1,2,5-Thiadiazolidin-3-one, 5-[(7R)-1-fluoro-5,6,7,8-tetrahydro-3-hydroxy-7-[(3-methylbutyl)amino]-2-naphthalenyl]-, 1,1-dioxide | C17H24FN3O4S | 2489404-97-7 | Details |
N-(4-CYANO-PHENYL)-GLYCINE | C9H8N2O2 | 42288-26-6 | Details |
Telatinib | C20H16ClN5O3 | 332012-40-5 | Details |
7-HYDROXY-4,8-DIMETHYLCOUMARIN | C11H10O3 | 4115-76-8 | Details |
N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide hydrochloride hydrate (1:2:1) | C27H40Cl2N6O4S | 1374744-69-0 | Details |
1,2,4,5-TETRABROMOBENZENE | C6H2Br4 | 636-28-2 | Details |
1,4-DIBROMO-2-FLUOROBENZENE | C6H3Br2F | 1435-52-5 | Details |
7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide | C27H29N5O3 | 1633350-06-7 | Details |
3,5-Dibromotoluene | C7H6Br2 | 1611-92-3 | Details |
2-IODO-5-METHYLTHIOPHENE | C5H5IS | 16494-36-3 | Details |
2-Iodotoluene | C7H7I | 615-37-2 | Details |
2-Bromobenzotrifluoride | C7H4BrF3 | 392-83-6 | Details |
2-Bromofluorene | C13H9Br | 1133-80-8 | Details |
4-Bromo-4'-methoxybiphenyl | C13H11BrO | 58743-83-2 | Details |
3-Pyrrolidinepropanenitrile, α-amino-2-oxo-, (αS,3S)- | C7H11N3O | 2742706-72-3 | Details |
(S)-2-Hydroxy-3-methoxy-3,3-diphenylpropionic acid methyl ester | C17H18O4 | 177036-78-1 | Details |
Epalrestat | C15H13NO3S2 | 82159-09-9 | Details |
1-Chloro-2-iodobenzene | C6H4ClI | 615-41-8 | Details |
3-[(2-aminoethoxy)methyl]-2,5,9-trimethyl-7H-furo[3,2-g]chromen-7-one hydrochloride | C17H20ClNO4 | 161262-45-9 | Details |
4-Bromo-4'-tert-butylbiphenyl | C16H17Br | 162258-89-1 | Details |
3-Azabicyclo[3.1.0]hexane-2-carboxylic acid, 3-[(2S)-2-amino-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-, (1R,2S,5S)- | C14H24N2O3 | 1063968-46-6 | Details |
3-BROMOPHENANTHRENE | C14H9Br | 715-50-4 | Details |
3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester | C27H26N6O3 | 211915-84-3 | Details |
Ningetinib | C31H29FN4O5 | 1394820-69-9 | Details |
1-BROMO-2-METHYLNAPHTHALENE | C11H9Br | 2586-62-1 | Details |
5-BROMO-2-IODOTOLUENE | C7H6BrI | 116632-39-4 | Details |
Ethyl 3-(pyridin-2-ylamino)propanoate | C10H14N2O2 | 103041-38-9 | Details |
1-Iodonaphthalene | C10H7I | 90-14-2 | Details |
Dihydrodiol Ibrutinib | C25H26N6O4 | 1654820-87-7 | Details |
1-((2R,5S)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one | C15H19N5O | 1792180-79-0 | Details |
Atogepant (MK-8031) | C29H23F6N5O3 | 1374248-81-3 | Details |
Simotinib | C25H26ClFN4O4 | 944258-89-3 | Details |
4-Iodo-1,2-dimethylbenzene | C8H9I | 31599-61-8 | Details |
2,4,6-TRIFLUOROBENZYL BROMIDE | C7H4BrF3 | 151411-98-2 | Details |
(1R,5S)-6,6-diMethyl-3-azabicyclo[3.1.0]hexane-2,4-dione | C7H9NO2 | 194421-56-2 | Details |
Zanubrutinib | C27H29N5O3 | 1691249-45-2 | Details |
1,4-Dibromo-2,5-dimethylbenzene | C8H8Br2 | 1074-24-4 | Details |
1,2-Diiodobenzene | C6H4I2 | 615-42-9 | Details |
4,4'-Dibromobiphenyl | C12H8Br2 | 92-86-4 | Details |
2,4-DIBROMOMESITYLENE | C9H10Br2 | 6942-99-0 | Details |
2-Bromonaphthalene | C10H7Br | 580-13-2 | Details |
4-Bromo-1-fluoro-2-iodobenzene | C6H3BrFI | 116272-41-4 | Details |
tert-Butyl ((S)-1-amino-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)carbamate | C12H21N3O4 | 2713439-69-9 | Details |
Poseltinib | C26H26N6O3 | 1353552-97-2 | Details |
5-fluoro-3,4-dimethoxy-2-methylbenzoic acid | C10H11FO4 | 1895436-51-7 | Details |
Product Total: Product Page: | ||||
24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 |